rs61742974

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_002334.4(LRP4):​c.129C>G​(p.Thr43Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00806 in 1,614,076 control chromosomes in the GnomAD database, including 905 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.043 ( 465 hom., cov: 32)
Exomes 𝑓: 0.0044 ( 440 hom. )

Consequence

LRP4
NM_002334.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.0860

Publications

1 publications found
Variant links:
Genes affected
LRP4 (HGNC:6696): (LDL receptor related protein 4) This gene encodes a member of the low-density lipoprotein receptor-related protein family. The encoded protein may be a regulator of Wnt signaling. Mutations in this gene are associated with Cenani-Lenz syndrome. [provided by RefSeq, May 2010]
LRP4 Gene-Disease associations (from GenCC):
  • Cenani-Lenz syndactyly syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • congenital myasthenic syndrome 17
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: ClinGen, PanelApp Australia, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • sclerosteosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • sclerosteosis 2
    Inheritance: SD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 11-46902853-G-C is Benign according to our data. Variant chr11-46902853-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 304905.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.086 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.146 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRP4NM_002334.4 linkc.129C>G p.Thr43Thr synonymous_variant Exon 2 of 38 ENST00000378623.6 NP_002325.2 O75096
LRP4XM_017017734.2 linkc.129C>G p.Thr43Thr synonymous_variant Exon 2 of 39 XP_016873223.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRP4ENST00000378623.6 linkc.129C>G p.Thr43Thr synonymous_variant Exon 2 of 38 1 NM_002334.4 ENSP00000367888.1 O75096
LRP4ENST00000534404.1 linkc.53-2475C>G intron_variant Intron 1 of 3 5 ENSP00000434763.1 E9PNJ5

Frequencies

GnomAD3 genomes
AF:
0.0430
AC:
6544
AN:
152138
Hom.:
465
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.149
Gnomad AMI
AF:
0.0164
Gnomad AMR
AF:
0.0177
Gnomad ASJ
AF:
0.000864
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000353
Gnomad OTH
AF:
0.0296
GnomAD2 exomes
AF:
0.0117
AC:
2940
AN:
251372
AF XY:
0.00846
show subpopulations
Gnomad AFR exome
AF:
0.157
Gnomad AMR exome
AF:
0.00879
Gnomad ASJ exome
AF:
0.00189
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000282
Gnomad OTH exome
AF:
0.00359
GnomAD4 exome
AF:
0.00442
AC:
6455
AN:
1461820
Hom.:
440
Cov.:
32
AF XY:
0.00375
AC XY:
2727
AN XY:
727224
show subpopulations
African (AFR)
AF:
0.154
AC:
5143
AN:
33480
American (AMR)
AF:
0.00957
AC:
428
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00149
AC:
39
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39698
South Asian (SAS)
AF:
0.000348
AC:
30
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53350
Middle Eastern (MID)
AF:
0.00572
AC:
33
AN:
5766
European-Non Finnish (NFE)
AF:
0.000151
AC:
168
AN:
1112012
Other (OTH)
AF:
0.0101
AC:
613
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
321
641
962
1282
1603
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
156
312
468
624
780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0430
AC:
6553
AN:
152256
Hom.:
465
Cov.:
32
AF XY:
0.0410
AC XY:
3049
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.149
AC:
6177
AN:
41498
American (AMR)
AF:
0.0177
AC:
270
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.000864
AC:
3
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000353
AC:
24
AN:
68036
Other (OTH)
AF:
0.0293
AC:
62
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
272
545
817
1090
1362
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
64
128
192
256
320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00302
Hom.:
13
Bravo
AF:
0.0505
Asia WGS
AF:
0.00866
AC:
30
AN:
3478
EpiCase
AF:
0.000327
EpiControl
AF:
0.000474

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 27, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Cenani-Lenz syndactyly syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cenani-Lenz syndactyly syndrome;C3280402:Sclerosteosis 2;C4225377:Congenital myasthenic syndrome 17 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.45
CADD
Benign
9.6
DANN
Benign
0.59
PhyloP100
0.086
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.6
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61742974; hg19: chr11-46924404; API